Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children
- PMID: 33407621
- PMCID: PMC7788734
- DOI: 10.1186/s12969-020-00492-z
Clinical characteristics and poor predictors of anti-NXP2 antibody-associated Chinese JDM children
Abstract
Background: Juvenile dermatomyositis (JDM) is a rare and sometimes fatal disease in children. The anti-NXP2 antibody is one of the most common antibodies and muscle ischaemia associated with NXP2 autoantibodies was a severe subtype of JDM. Further information is needed regarding clinical characteristics and factors associated with poor prognosis. But there are no reports about clinical characteristics and high risk factor of poor prognosis. For the first time, we introduced the clinical characteristics and poor predictors of anti-NXP2 antibody-associated juvenile dermatomyositis in Chinese children.
Methods: Twenty-six patients with anti-NXP2 antibody-related JDM from 85 JDM Chinese patients were diagnosed from January 2016 to November 2019. Logistic regression was used to analyze the risk factors for refractory cases and mortality.
Results: The ratio of male to female was 1:1.9. The median age of onset was 4.5 (1-13) years. Twenty-four cases (92.3%) had rash and muscle weakness. Treatments included glucocorticoids, immunosuppressive agents, biological agents (7 cases), plasma exchange, Janus kinase inhibitor (7 cases) and autologous stem cell transplant (1 case). Refractory JDM patients (11/26, 42.3%) were associated with edema, skin ulcer, muscle strength<=grade 3, CD4/CD8 ratio < 1.4 and ferritin > 200μg/ml. Among 6 cases (6/26, 23.1%) with severe gastrointestinal involvement, 5 cases died and 1 case survived after autologous stem cell transplant (ASCT). The risk factors for gastrointestinal involvement and mortality were edema, skin ulcer, severe muscle weakness (dysphagia/ hoarseness/ soft voice), BMI < 15 and ANA positive.
Conclusions: Edema, skin ulcer and severe muscle weakness predicted refractory disease, GI involvement, and mortality in anti-NXP2 antibody-positive JDM of Chinese children. Decreased CD4/CD8 ratio and high ferritin related with refractory cases, and very low BMI and ANA (+) are probably, associated with gastrointestinal involvement and mortality.
Trial registration: http://www.chictr.org.cn/showproj.aspx?proj=49846 .
Keywords: Anti-nuclear matrix protein 2; Chinese; Juvenile dermatomyositis.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Gastrointestinal perforation in anti-NXP2 antibody-associated juvenile dermatomyositis: case reports and a review of the literature.Pediatr Rheumatol Online J. 2021 Jan 6;19(1):2. doi: 10.1186/s12969-020-00486-x. Pediatr Rheumatol Online J. 2021. PMID: 33407602 Free PMC article. Review.
-
Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.Rheumatology (Oxford). 2014 Dec;53(12):2204-8. doi: 10.1093/rheumatology/keu259. Epub 2014 Jul 1. Rheumatology (Oxford). 2014. PMID: 24987158 Free PMC article.
-
Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.Rheumatology (Oxford). 2018 May 1;57(5):873-879. doi: 10.1093/rheumatology/kex516. Rheumatology (Oxford). 2018. PMID: 29474663
-
Clinical subsets of juvenile dermatomyositis classified by myositis-specific autoantibodies: Experience at a single center in Japan.Mod Rheumatol. 2019 Sep;29(5):802-807. doi: 10.1080/14397595.2018.1511025. Epub 2018 Sep 10. Mod Rheumatol. 2019. PMID: 30092736
-
[Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].Zhonghua Er Ke Za Zhi. 2019 Dec 2;57(12):928-933. doi: 10.3760/cma.j.issn.0578-1310.2019.12.007. Zhonghua Er Ke Za Zhi. 2019. PMID: 31795559 Review. Chinese.
Cited by
-
Juvenile dermatomyositis and nephrotic syndrome: A case report and a mini literature review.Front Pediatr. 2023 May 2;11:1149785. doi: 10.3389/fped.2023.1149785. eCollection 2023. Front Pediatr. 2023. PMID: 37205220 Free PMC article.
-
An update on autoantibodies in the idiopathic inflammatory myopathies.Nat Rev Rheumatol. 2025 Jan;21(1):46-62. doi: 10.1038/s41584-024-01188-4. Epub 2024 Nov 28. Nat Rev Rheumatol. 2025. PMID: 39609638 Review.
-
[Long-term rituximab treatment of refractory idiopathic inflammatory myopathy: A report of 3 cases].Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Dec 18;53(6):1191-1195. doi: 10.19723/j.issn.1671-167X.2021.06.031. Beijing Da Xue Xue Bao Yi Xue Ban. 2021. PMID: 34916704 Free PMC article. Chinese.
-
Anti-nuclear matrix protein 2 antibody-associated juvenile dermatomyositis with gastrointestinal perforations was successfully treated with traditional therapeutic drugs combined with vedolizumab: a case report after a long-term follow-up and a review of the literature.Front Pediatr. 2025 Jan 20;12:1522559. doi: 10.3389/fped.2024.1522559. eCollection 2024. Front Pediatr. 2025. PMID: 39902228 Free PMC article.
-
Janus Kinase Inhibitors and Interstitial Lung Disease Associated With Pediatric Rheumatic Diseases: An Unexplored Field.Cureus. 2023 Dec 21;15(12):e50928. doi: 10.7759/cureus.50928. eCollection 2023 Dec. Cureus. 2023. PMID: 38143732 Free PMC article. Review.
References
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials